Appropriately testing patients with intermediate risk for coronary artery disease

How well are we doing?

Ali A. Alsaad, Brian P Shapiro

Research output: Contribution to journalArticle

Abstract

Background: Cardiovascular risk assessment and stratification of stable coronary artery disease represents a pivotal component of coronary artery disease management. The introduction of risk stratification tools has advanced the detection of patients with intermediate to high risk for coronary artery events. These patients will ultimately undergo non-invasive and invasive cardiovascular testing. Objective: To synthesise evidence illustrating risk stratification tools and non-invasive testing for patients with intermediate risk for coronary artery disease and suggest a simple method for clinicians to follow prior to ordering non-invasive cardiovascular testing. Study selection: Literature review of PubMed and MEDLINE Central on studies and evidence highlighting the appropriate use criteria for radionuclide myocardial perfusion imaging. Findings and conclusions: Overtestingusing myocardial perfusion imaging is well documented in several studies in the literature. Few studies highlighted the importance of the appropriate use criteria for radionuclide myocardial perfusion imaging, which can reduce unnecessary testing in patients with suspected coronary artery disease. Herein, we propose 'Simple Steps to Follow' to be considered by clinicians prior to ordering radionuclide myocardial perfusion imaging. The target audience of this article is internal and family medicine primary care physicians and other non-cardiologist physicians.

Original languageEnglish (US)
JournalEvidence-Based Medicine
DOIs
StateAccepted/In press - May 5 2018

Fingerprint

Myocardial Perfusion Imaging
Coronary Artery Disease
Radioisotopes
Primary Care Physicians
Internal Medicine
Disease Management
PubMed
MEDLINE
Coronary Vessels
Physicians

Keywords

  • adult cardiology
  • coronary heart disease
  • ischaemic heart disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{5bcc9443356a4631a955193ccbbe85a0,
title = "Appropriately testing patients with intermediate risk for coronary artery disease: How well are we doing?",
abstract = "Background: Cardiovascular risk assessment and stratification of stable coronary artery disease represents a pivotal component of coronary artery disease management. The introduction of risk stratification tools has advanced the detection of patients with intermediate to high risk for coronary artery events. These patients will ultimately undergo non-invasive and invasive cardiovascular testing. Objective: To synthesise evidence illustrating risk stratification tools and non-invasive testing for patients with intermediate risk for coronary artery disease and suggest a simple method for clinicians to follow prior to ordering non-invasive cardiovascular testing. Study selection: Literature review of PubMed and MEDLINE Central on studies and evidence highlighting the appropriate use criteria for radionuclide myocardial perfusion imaging. Findings and conclusions: Overtestingusing myocardial perfusion imaging is well documented in several studies in the literature. Few studies highlighted the importance of the appropriate use criteria for radionuclide myocardial perfusion imaging, which can reduce unnecessary testing in patients with suspected coronary artery disease. Herein, we propose 'Simple Steps to Follow' to be considered by clinicians prior to ordering radionuclide myocardial perfusion imaging. The target audience of this article is internal and family medicine primary care physicians and other non-cardiologist physicians.",
keywords = "adult cardiology, coronary heart disease, ischaemic heart disease",
author = "Alsaad, {Ali A.} and Shapiro, {Brian P}",
year = "2018",
month = "5",
day = "5",
doi = "10.1136/bmjebm-2017-110832",
language = "English (US)",
journal = "Evidence-Based Medicine",
issn = "1356-5524",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Appropriately testing patients with intermediate risk for coronary artery disease

T2 - How well are we doing?

AU - Alsaad, Ali A.

AU - Shapiro, Brian P

PY - 2018/5/5

Y1 - 2018/5/5

N2 - Background: Cardiovascular risk assessment and stratification of stable coronary artery disease represents a pivotal component of coronary artery disease management. The introduction of risk stratification tools has advanced the detection of patients with intermediate to high risk for coronary artery events. These patients will ultimately undergo non-invasive and invasive cardiovascular testing. Objective: To synthesise evidence illustrating risk stratification tools and non-invasive testing for patients with intermediate risk for coronary artery disease and suggest a simple method for clinicians to follow prior to ordering non-invasive cardiovascular testing. Study selection: Literature review of PubMed and MEDLINE Central on studies and evidence highlighting the appropriate use criteria for radionuclide myocardial perfusion imaging. Findings and conclusions: Overtestingusing myocardial perfusion imaging is well documented in several studies in the literature. Few studies highlighted the importance of the appropriate use criteria for radionuclide myocardial perfusion imaging, which can reduce unnecessary testing in patients with suspected coronary artery disease. Herein, we propose 'Simple Steps to Follow' to be considered by clinicians prior to ordering radionuclide myocardial perfusion imaging. The target audience of this article is internal and family medicine primary care physicians and other non-cardiologist physicians.

AB - Background: Cardiovascular risk assessment and stratification of stable coronary artery disease represents a pivotal component of coronary artery disease management. The introduction of risk stratification tools has advanced the detection of patients with intermediate to high risk for coronary artery events. These patients will ultimately undergo non-invasive and invasive cardiovascular testing. Objective: To synthesise evidence illustrating risk stratification tools and non-invasive testing for patients with intermediate risk for coronary artery disease and suggest a simple method for clinicians to follow prior to ordering non-invasive cardiovascular testing. Study selection: Literature review of PubMed and MEDLINE Central on studies and evidence highlighting the appropriate use criteria for radionuclide myocardial perfusion imaging. Findings and conclusions: Overtestingusing myocardial perfusion imaging is well documented in several studies in the literature. Few studies highlighted the importance of the appropriate use criteria for radionuclide myocardial perfusion imaging, which can reduce unnecessary testing in patients with suspected coronary artery disease. Herein, we propose 'Simple Steps to Follow' to be considered by clinicians prior to ordering radionuclide myocardial perfusion imaging. The target audience of this article is internal and family medicine primary care physicians and other non-cardiologist physicians.

KW - adult cardiology

KW - coronary heart disease

KW - ischaemic heart disease

UR - http://www.scopus.com/inward/record.url?scp=85049195679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049195679&partnerID=8YFLogxK

U2 - 10.1136/bmjebm-2017-110832

DO - 10.1136/bmjebm-2017-110832

M3 - Article

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

SN - 1356-5524

ER -